Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| SEGG | Lottery.com | $3.55 | $2.27 | 177.54% | 104.1M | $6.6M | $0.46$26.45 |
| CRVS | Corvus Pharmaceuticals | $18.28 | $10.23 | 127.08% | 1.7M | $601M | $2.54$19.12 |
| RAPT | Rapt Therapeutics | $57.51 | $22.41 | 63.85% | 862.2K | $973M | $5.67$57.61 |
| SHPH | Shuttle Pharmaceuticals | $2.57 | $0.94 | 57.36% | 119.1M | $2.6M | $1.26$25.25 |
| TWG | Top Wealth Group | $5.39 | $1.91 | 54.88% | 46.5M | $5.1M | $3.25$28.11 |
| POLA | Polar Power | $2.50 | $0.82 | 48.81% | 65M | $4.5M | $1.31$5.75 |
| ACRS | Aclaris Therapeutics | $3.90 | $1.28 | 48.66% | 7.9M | $284M | $1.05$3.96 |
| BTTC | Black Titan | $2.50 | $0.80 | 47.06% | 69.3M | $15M | $1.51$39.00 |
| ICON | Icon Energy | $2.74 | $0.80 | 41.25% | 25M | - | $1.94$440.00 |
| NUAI | New Era Energy & Digital | $5.90 | $1.57 | 36.26% | 17.4M | $231M | $0.32$7.59 |
Related Articles
Featured Article
2 Cathie Wood Stocks That Could Soar in 2024, According to Wall Street
George Budwell, PhD|Dec 27, 2023
Wall Street is uber-bullish on these two Ark Invest holdings.
Thermo Fisher Increases Its Buyout Price for Qiagen, but Investors Ask for More
Luis Sanchez CFA|Aug 4, 2020
Will Thermo Fisher be able to complete its deal to acquire Qiagen, or will shareholders vote it down?
Here's How Qiagen Trounced Q1 Estimates
Keith Speights|May 7, 2020
The molecular diagnostics company blew past Wall Street's top- and bottom-line expectations in the first quarter for one main reason.
Advertisement
Coronavirus Test-makers Ramp Up Production
Brian Orelli, PhD|Mar 18, 2020
Multiple companies have gained regulatory approvals in recent days.
Will COVID-19 Derail New Drugs?
David Haen|Mar 18, 2020
Disruptions in clinical trials and delayed regulatory decisions could slow the rate of new drug approvals.
FDA Warns About Potential Supply Chain Issues for Coronavirus Tests
Keith Speights|Mar 16, 2020
There's no shortage yet, but the FDA is working to address supply issues with a key component of COVID-19 diagnostics tests.
Stock Market News: Tilray Comes Down; Thermo Fisher Makes a Big Buy
Dan Caplinger|Mar 3, 2020
The stock market was turbulent Tuesday morning.
Thermo Fisher Scientific to Spend $11.5 Billion Upgrading Its DNA Testing Game
Cory Renauer|Mar 3, 2020
The world's leading provider of scientific tools will buy QIAGEN and its growing menu of molecular diagnostic products.
Should Investors Buy Qiagen's Stock for Its Coronavirus Detection Kit?
David Haen|Feb 29, 2020
Amid ever-rising numbers of infected individuals, Qiagen believes it offers a quick solution to expedite testing for the virus.
Better Buy: Exact Sciences vs. Qiagen
David Haen|Jan 23, 2020
One just wrapped up a multi-billion-dollar acquisition while the other elected to remain independent.
